The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.38BCNY
506.75M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue (TTM)
6.89BCNY
1.03B · vs all stocks (USD)
Updated Nov 19, 2026
Profit Margin
-12.70%
Updated Nov 19, 2026
Beta
0.4040x
vs all stocks
Updated Nov 19, 2026
52-Week Change
-32.41%
vs all stocks
Updated Nov 19, 2026
Market Capitalization
3.38BCNY
506.75M · vs all stocks (USD)
Updated Nov 19, 2026
Enterprise Value
6.22BCNY
932.53M · vs all stocks (USD)
Updated Nov 19, 2026
Forward P/E
-50.00x
Updated Nov 19, 2026
Price to Sales (TTM)
0.5234x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.49×.Updated Nov 19, 2026
Price to Book (MRQ)
11.18x
Updated Nov 19, 2026
Enterprise to Revenue
0.9020x
Updated Nov 19, 2026
Enterprise to EBITDA
-7.07x
Updated Nov 19, 2026
Gross Margin
22.18%
Updated Nov 19, 2026
Profit Margin
-12.70%
Updated Nov 19, 2026
Operating Margin
-11.25%
Updated Nov 19, 2026
Return on Assets (TTM)
-5.40%
Updated Nov 19, 2026
Return on Equity (TTM)
-112.23%
Updated Nov 19, 2026
Revenue (TTM)
6.89BCNY
1.03B · vs all stocks (USD)
Updated Nov 19, 2026
Revenue per Share (TTM)
10.64CNYUpdated Nov 19, 2026
Quarterly Revenue Growth
-18.50%
Updated Nov 19, 2026
Gross Profit (TTM)
1.50BCNY
225.07M · vs all stocks (USD)
Updated Nov 19, 2026
EBITDA (TTM)
-879.46MCNY
-131.91M · vs all stocks (USD)
Updated Nov 19, 2026
Net Income (TTM)
-875.55MCNY
-131.32M · vs all stocks (USD)
Updated Nov 19, 2026
Operating Cash Flow (TTM)
86.90MCNY
13.03M · vs all stocks (USD)
Updated Nov 19, 2026
Levered Free Cash Flow (TTM)
185.91MCNY
27.88M · vs all stocks (USD)
Updated Nov 19, 2026
5-Year Average Dividend Yield
0.85%
vs all stocks
Updated Nov 19, 2026
Payout Ratio
52.63%
Updated Nov 19, 2026
Minority Interest (Equity)
37.07MCNYFY2025 · Dec 31, 2025
Revenue
8.28BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
6.43BCNYFY2025 · Dec 31, 2025
Gross Profit
1.85BCNYFY2025 · Dec 31, 2025
Operating Income
-597.74MCNY
-89.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-940.99MCNYFY2025 · Dec 31, 2025
Income Tax Expense
17.47MCNYFY2025 · Dec 31, 2025
Net Income
-958.46MCNYFY2025 · Dec 31, 2025
EBIT
-860.81MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-147.03MCNYFY2025 · Dec 31, 2025
Research & Development
5.44MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
665.94MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
115.40MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
8.32MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
80.18MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.46CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.46CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
655.15MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
655.15MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-958.46MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.94MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
72.34MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-115.59MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
488.63MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-958.46MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
286.55MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
107.00MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
637.25MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-187.93MCNYFY2025 · Dec 31, 2025
Sale of Investments
78.76MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-13.22KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-109.18MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.85BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.77BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-26.49MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-454.61MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-400.63MCNYFY2025 · Dec 31, 2025
Shares Outstanding
662.46MSharesUpdated Nov 19, 2026
Float Shares
410.89MSharesUpdated Nov 19, 2026
% Held by Insiders
38.65%
vs all stocks
Updated Nov 19, 2026
% Held by Institutions
0.77%
vs all stocks
Updated Nov 19, 2026
Total Cash (MRQ)
1.16BCNY
173.40M · vs all stocks (USD)
Updated Nov 19, 2026
Total Cash per Share (MRQ)
1.76CNYUpdated Nov 19, 2026
Total Debt (MRQ)
3.75BCNY
561.91M · vs all stocks (USD)
Updated Nov 19, 2026
Total Debt to Equity (MRQ)
10.97x
Updated Nov 19, 2026
Current Ratio (MRQ)
0.4060x
Updated Nov 19, 2026
Book Value per Share (MRQ)
0.4920CNYUpdated Nov 19, 2026
Total Assets
8.45BCNY
1.27B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.01BCNYFY2025 · Dec 31, 2025
Total Liabilities
7.59BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
6.44BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.46BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
6.12BCNYFY2025 · Dec 31, 2025
Cash
477.03MCNYFY2025 · Dec 31, 2025
Cash Equivalents
66.31MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
543.34MCNYFY2025 · Dec 31, 2025
Accounts Receivable
269.32MCNYFY2025 · Dec 31, 2025
Inventory
863.35MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.61BCNYFY2025 · Dec 31, 2025
Short-term Debt
1.68BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
257.12MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.33BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
662.46MCNYFY2025 · Dec 31, 2025
Retained Earnings
-1.12BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
858.26MCNY
128.73M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
19.30MCNYFY2025 · Dec 31, 2025
52-Week Low
4.90CNYUpdated Nov 19, 2026
52-Week High
9.56CNYUpdated Nov 19, 2026
52-Week Change
-32.41%
vs all stocks
Updated Nov 19, 2026
Beta
0.4040x
vs all stocks
Updated Nov 19, 2026
50-Day MA
6.29CNYUpdated Nov 19, 2026
200-Day MA
6.19CNYUpdated Nov 19, 2026
Avg 10-Day Volume
50.87MSharesUpdated Nov 19, 2026
Avg 30-Day Volume
71.68MSharesUpdated Nov 19, 2026
Diluted EPS (TTM)
-1.35CNYUpdated Nov 19, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Elevated Leverage on Three DenominatorsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Elevated Leverage on Three DenominatorsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Elevated Leverage on Three DenominatorsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone